[
  {
    "ts": null,
    "headline": "J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why",
    "summary": "J&J sees Innovative Medicines growth in 2025, fueled by oncology and immunology drugs, despite steep Stelara sales erosion.",
    "url": "https://finnhub.io/api/news?id=510b253192fdb132cea1ccfd28b93b59fe7115cae0c5a0063e558f4b18cc5161",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758213000,
      "headline": "J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why",
      "id": 136801200,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "J&J sees Innovative Medicines growth in 2025, fueled by oncology and immunology drugs, despite steep Stelara sales erosion.",
      "url": "https://finnhub.io/api/news?id=510b253192fdb132cea1ccfd28b93b59fe7115cae0c5a0063e558f4b18cc5161"
    }
  }
]